| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
|
JAMA
|
2011
|
4.09
|
|
2
|
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.
|
Circulation
|
2006
|
1.35
|
|
3
|
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.
|
Circulation
|
2008
|
1.14
|
|
4
|
Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment elevation myocardial infarction: findings from the CRUSADE initiative.
|
Am Heart J
|
2010
|
1.02
|
|
5
|
Medical records and quality of care in acute coronary syndromes: results from CRUSADE.
|
Arch Intern Med
|
2008
|
1.00
|
|
6
|
Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over time.
|
J Am Geriatr Soc
|
2009
|
0.91
|
|
7
|
Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome.
|
Am Heart J
|
2011
|
0.88
|
|
8
|
Reporting and representation of race/ethnicity in published randomized trials.
|
Am Heart J
|
2009
|
0.81
|
|
9
|
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial.
|
Circulation
|
2010
|
0.80
|
|
10
|
Changes in beliefs about medications during long-term care for ischemic heart disease.
|
Am Heart J
|
2010
|
0.79
|
|
11
|
Risk factor management after acute coronary syndromes.
|
Heart
|
2009
|
0.79
|
|
12
|
Sex differences in medical care after acute myocardial infarction: what can be done to address the problem?
|
Womens Health (Lond Engl)
|
2009
|
0.77
|
|
13
|
Dual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review.
|
J Thromb Thrombolysis
|
2014
|
0.76
|
|
14
|
A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation.
|
Ther Drug Monit
|
2017
|
0.75
|
|
15
|
Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant Patients.
|
Ther Drug Monit
|
2016
|
0.75
|
|
16
|
Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine.
|
Ther Drug Monit
|
2016
|
0.75
|
|
17
|
Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach.
|
Clin Neuropharmacol
|
2016
|
0.75
|
|
18
|
Extended-release ranolazine: critical evaluation of its use in stable angina.
|
Vasc Health Risk Manag
|
2011
|
0.75
|
|
19
|
Highlights from the 56th annual scientific sessions of the American College of Cardiology: March 25 to 27, 2007, Atlanta, Georgia.
|
Am Heart J
|
2007
|
0.75
|
|
20
|
Highlights from the American College of Cardiology Annual Scientific Session 2005: March 6 to 9, 2005, Orlando, Florida.
|
Am Heart J
|
2005
|
0.75
|
|
21
|
Clinical use of novel antithrombotic agents in the management of acute coronary syndromes.
|
Pathophysiol Haemost Thromb
|
2003
|
0.75
|
|
22
|
Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene.
|
Can J Psychiatry
|
2004
|
0.75
|
|
23
|
Highlights from American Heart Association, November 4-7, 2007, Orlando, Florida, USA. Late-breaking trials summary.
|
Am Heart J
|
2008
|
0.75
|